pargyline has been researched along with Meniere Disease in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Meniere Disease: A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattes, JA | 1 |
1 other study available for pargyline and Meniere Disease
| Article | Year |
|---|---|
MAOIs and Ménière's syndrome.
Topics: Adult; Female; Humans; Isocarboxazid; Meniere Disease; Monoamine Oxidase Inhibitors; Pargyline; Phen | 1990 |